ID   Panc02
AC   CVCL_D627
SY   Panc-02; Panc 02; Pan02; PAN 02; Panc02-H0
DR   BTO; BTO:0005175
DR   CCRID; 1101MOU-PUMC000446
DR   ChEMBL-Cells; CHEMBL4483161
DR   ChEMBL-Targets; CHEMBL4483283
DR   CLS; 300501
DR   NCI-DTP; PAN 02
DR   PubChem_Cell_line; CVCL_D627
DR   Wikidata; Q54937552
RX   PubMed=6692374;
RX   PubMed=12754403;
RX   PubMed=20805420;
RX   PubMed=21720167;
RX   PubMed=22208613;
CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=6692374;
RA   Corbett T.H., Roberts B.J., Leopold W.R., Peckham J.C., Wilkoff L.J.,
RA   Griswold D.P. Jr., Schabel F.M. Jr.;
RT   "Induction and chemotherapeutic response of two transplantable ductal
RT   adenocarcinomas of the pancreas in C57BL/6 mice.";
RL   Cancer Res. 44:717-726(1984).
//
RX   PubMed=12754403; DOI=10.1385/IJGC:29:1:37;
RA   Wang B.-L., Shi Q., Abbruzzese J.L., Xiong Q.-H., Le X.-D., Xie K.-P.;
RT   "A novel, clinically relevant animal model of metastatic pancreatic
RT   adenocarcinoma biology and therapy.";
RL   Int. J. Pancreatol. 29:37-46(2001).
//
RX   PubMed=20805420; DOI=10.4049/jimmunol.0902609;
RA   Gnerlich J.L., Mitchem J.B., Weir J.S., Sankpal N.V., Kashiwagi H.,
RA   Belt B.A., Porembka M.R., Herndon J.M., Eberlein T.J.,
RA   Goedegebuure P., Linehan D.C.;
RT   "Induction of Th17 cells in the tumor microenvironment improves
RT   survival in a murine model of pancreatic cancer.";
RL   J. Immunol. 185:4063-4071(2010).
//
RX   PubMed=21720167; DOI=10.1159/000329413;
RA   Partecke L.I., Sendler M., Kaeding A., Weiss F.U., Mayerle J.,
RA   Dummer A., Nguyen T.D., Albers N., Speerforck S., Lerch M.M.,
RA   Heidecke C.-D., von Bernstorff W., Stier A.;
RT   "A syngeneic orthotopic murine model of pancreatic adenocarcinoma in
RT   the C57/BL6 mouse using the Panc02 and 6606PDA cell lines.";
RL   Eur. Surg. Res. 47:98-107(2011).
//
RX   PubMed=22208613; DOI=10.2174/156652412799218868;
RA   Wang Y., Zhang Y., Yang J., Ni X., Liu S., Li Z., Hodges S.E.,
RA   Fisher W.E., Brunicardi F.C., Gibbs R.A., Gingras M.-C., Li M.;
RT   "Genomic sequencing of key genes in mouse pancreatic cancer cells.";
RL   Curr. Mol. Med. 12:331-341(2012).
//